AF

Cardiovascular
243 drugs in development·121 companies·1 clinical trial

Drug Pipeline by Phase

Approved(100)
DrugCompany
ABRAXANEImmunityBio, Inc. (IBRX)
acetylcysteineENGENE HOLDINGS INC. (ENGN)
afinitorNovartis AG (NVS)
alendronateMylan II B.V. (MYL)
almotriptan malateMylan II B.V. (MYL)
AMNIOCORDMiMedx Group Inc (MDXG)
AMNIOEFFECTMiMedx Group Inc (MDXG)
axitinibAptinyx Inc. (APTX)
bexaroteneAmneal Pharmaceuticals, Inc. (AMRX)
braftoviARRAY BIOPHARMA INC (ARRY)
bupropionDesign Therapeutics, Inc. (DSGN)
bupropionPrestige Consumer Healthcare Inc. (PBH)
bupropionImpax Laboratories, LLC (IPXL)
bupropionAlphaTON Capital Corp (ATON)
butalbitalLANNETT CO INC (LCI)
butalbitalQIAGEN N.V. (QGEN)
butalbitalOptec International, Inc. (GM)
caystonGILEAD SCIENCES, INC. (GILD)
chenodiolOptec International, Inc. (GM)
clobetasol propionate ophthalmic suspension 0.05%HYPERION DEFI, INC. (HYPD)
clofarabineMersana Therapeutics, Inc. (MRSN)
clofarabineDR REDDYS LABORATORIES LTD (RDY)
cromolynAGILE THERAPEUTICS INC (AGRX)
diphenhydramineACHIEVE LIFE SCIENCES, INC. (ACHV)
diphenhydramineMiromatrix Medical Inc. (MIRO)
docetaxelAmneal Pharmaceuticals, Inc. (AMRX)
Double - Coptis SuppositoryChina Health Industries Holdings, Inc. (CHHE)
drug applicationLiquidia Corp (LQDA)
emblaveoAbbVie Inc. (ABBV)
EPICORDMiMedx Group Inc (MDXG)
esomeprazole magnesiumEXELIXIS, INC. (EXEL)
everolimusMylan II B.V. (MYL)
gloperbaSCILEX HOLDING CO (SCLX)
hp+detect™BIOMERICA INC (BMRA)
ibrancePFIZER INC (PFE)
iluvienALIMERA SCIENCES INC (ALIM)
ILUVIENANI PHARMACEUTICALS INC (ANIP)
imatinibTeva Pharmaceutical Industries Limited (TEVA)
imatinibMylan II B.V. (MYL)
imatinibAptinyx Inc. (APTX)
imatinibSUNSET ISLAND GROUP (SUN)
imatinibDR REDDYS LABORATORIES LTD (RDY)
imatinibAmneal Pharmaceuticals, Inc. (AMRX)
ImbruvicaRoyalty Pharma plc (RPRX)
imipramineOXFORD IMMUNOTEC GLOBAL PLC (OXFD)
imkeldiCG Oncology, Inc. (CGON)
Indometacin and Furazolidone SuppositoriesChina Health Industries Holdings, Inc. (CHHE)
InluriyoELI LILLY & Co (LLY)
INVEGA HAFYERA / BYANNLIAlkermes plc. (ALKS)
INVEGA SUSTENNA / XEPLIONAlkermes plc. (ALKS)
jaypircaLOXO ONCOLOGY, INC. (LOXO)
JaypircaELI LILLY & Co (LLY)
Jaypirca®ELI LILLY & Co (LLY)
kalydecoVERTEX PHARMACEUTICALS INC / MA (VRTX)
ksortIMMUCOR INC (BLUD)
lamotrigineTeva Pharmaceutical Industries Limited (TEVA)
letairisGILEAD SCIENCES, INC. (GILD)
leucovorin calcium preservative freeSeagen Inc. (SGEN)
leucovorin calcium preservative freeMylan II B.V. (MYL)
mekinistNovartis AG (NVS)
mektoviARRAY BIOPHARMA INC (ARRY)
mesalamineAmneal Pharmaceuticals, Inc. (AMRX)
multaqSanofi (SNY)
naftifineAmneal Pharmaceuticals, Inc. (AMRX)
nanoss strataXtant Medical Holdings, Inc. (XTNT)
neoprofenUltragenyx Pharmaceutical Inc. (RARE)
neostigmine methylAmphastar Pharmaceuticals, Inc. (AMPH)
nexobridMediWound Ltd. (MDWD)
NiktimvoSyndax Pharmaceuticals Inc (SNDX)
nilutamideANI PHARMACEUTICALS INC (ANIP)
nPulse ConsolePulse Biosciences Inc Common Stock (DE) (PLSE)
ojemdaDay One Biopharmaceuticals, Inc. (DAWN)
OlumiantELI LILLY & Co (LLY)
Olumiant®ELI LILLY & Co (LLY)
opcicon one-stepSUNSET ISLAND GROUP (SUN)
opdivo qvantigBRISTOL MYERS SQUIBB CO (BMY)
ozurdexAbbVie Inc. (ABBV)
paclitaxelMylan II B.V. (MYL)
paliperidoneInventiva S.A. (IVA)
promactaNovartis AG (NVS)
propafenoneMylan II B.V. (MYL)
propylgallateCHINA PHARMA HOLDINGS, INC. (CPHI)
Propylgallate for InjectionCHINA PHARMA HOLDINGS, INC. (CPHI)
simpligraftXtant Medical Holdings, Inc. (XTNT)
simplimaxXtant Medical Holdings, Inc. (XTNT)
sirolimusAmneal Pharmaceuticals, Inc. (AMRX)
timololAmneal Pharmaceuticals, Inc. (AMRX)
tobi podhalerViatris Inc (VTRS)
trikaftaVERTEX PHARMACEUTICALS INC / MA (VRTX)
triviumXtant Medical Holdings, Inc. (XTNT)
TyvytELI LILLY & Co (LLY)
Tyvyt®ELI LILLY & Co (LLY)
ultramistSANUWAVE Health Inc. (SNWV)
ursodiolOptec International, Inc. (GM)
venlafaxineTeva Pharmaceutical Industries Limited (TEVA)
veregenANI PHARMACEUTICALS INC (ANIP)
vykouraKaya Holdings, Inc. (KAYS)
zafirlukastDR REDDYS LABORATORIES LTD (RDY)
Zenocutuzumab (Zeno) / BIZENGRI® (zenocutuzumab-zbco)Merus N.V. (MRUS)
zoledronic acidAmneal Pharmaceuticals, Inc. (AMRX)
Phase 3(49)
DrugCompany
A10 and AS2-1 AntineoplastonBURZYNSKI RESEARCH INSTITUTE INC (BZYR)
AbataceptCrinetics Pharmaceuticals, Inc. (CRNX)
AbataceptENANTA PHARMACEUTICALS INC (ENTA)
abelacimabDianthus Therapeutics, Inc. /DE/ (DNTH)
Amivantamab + FOLFIRIIGM Biosciences, Inc. (IGMS)
Androgen-deprivation TherapyCrinetics Pharmaceuticals, Inc. (CRNX)
APL-3007, pegcetacoplanApellis Pharmaceuticals, Inc. (APLS)
axatilimabIncyte Corp. (INCY)
belumosudilSanofi (SNY)
best available therapyIncyte Corp. (INCY)
best available treatmentIncyte Corp. (INCY)
BicalutamideMyovant Sciences Ltd. (MYOV)
Consolidation TherapyCrinetics Pharmaceuticals, Inc. (CRNX)
EncorafenibIGM Biosciences, Inc. (IGMS)
extracorporeal photopheresisIncyte Corp. (INCY)
FlutamideMyovant Sciences Ltd. (MYOV)
golidocitinibCrinetics Pharmaceuticals, Inc. (CRNX)
golidocitinibMerus N.V. (MRUS)
imatinibIncyte Corp. (INCY)
imu-856IMMUNIC, INC. (IMUX)
inca034176Incyte Corp. (INCY)
infliximabIncyte Corp. (INCY)
itacitinibIncyte Corp. (INCY)
itolizumabEquillium, Inc. (EQ)
lumateperoneIntra-Cellular Therapies, Inc. (ITCI)
lumateperone LAIIntra-Cellular Therapies, Inc. (ITCI)
Maintenance TherapyCrinetics Pharmaceuticals, Inc. (CRNX)
mechanistic target of rapamycin inhibitorsIncyte Corp. (INCY)
mycophenolate mofetilIncyte Corp. (INCY)
NilutamideMyovant Sciences Ltd. (MYOV)
nPulse Cardiac Catheter SystemPulse Biosciences Inc Common Stock (DE) (PLSE)
nPulse Cardiac Surgical Clamp (nsPFA Cardiac Surgery System)Pulse Biosciences Inc Common Stock (DE) (PLSE)
pacritinibGH Research PLC (GHRS)
PegcetacoplanApellis Pharmaceuticals, Inc. (APLS)
Pegcetacoplan (systemic)Apellis Pharmaceuticals, Inc. (APLS)
pentostatinIncyte Corp. (INCY)
PlinabulinBeyondSpring Inc. (BYSI)
prochymalMesoblast Limited (MESO)
Re-induction TherapyCrinetics Pharmaceuticals, Inc. (CRNX)
remestemcel-l-rkndMesoblast Limited (MESO)
Rescue medications for sacituzumab tirumotecanMerus N.V. (MRUS)
revita dmr systemFractyl Health Inc. (GUTS)
Rina-SMerus N.V. (MRUS)
sacituzumab govitecanPhoenix Life Sciences International Limited. (PLSI)
sdatevHumacyte Inc. (HUMA)
surzebiclimabBeOne Medicines Ltd. (ONC)
Systemic pegcetacoplanApellis Pharmaceuticals, Inc. (APLS)
tacrolimusIncyte Corp. (INCY)
Zipalertinib (CLN-081/TAS6417)Cullinan Therapeutics, Inc. (CGEM)
Phase 2(29)
Unknown(16)

Compare drugs

Frequently asked questions

How many drugs are in development for AF?

BioSniper tracks 243 drugs in development for AF across 121 companies.

How many clinical trials target AF?

There are 1 clinical trial targeting AF tracked by BioSniper.

Deep-dive into AF

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis